Navigation Links
Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM)
Date:11/23/2009

Nurtur Receives Accreditation for Five Population Health Programs

LOVELAND, Ohio, Nov. 23 /PRNewswire-USNewswire/ -- The Population Health Impact Institute (PHII), a non-profit 501(c)(3) organization, is pleased to announced that PHII's Board of Directors has approved the Healthcare Transparency Accreditation Program, v 1.0 (H-TAP(TM)) after two years of development. Nurtur(TM), a life, health, and wellness company based in Farmington, CT is the first organization to receive the H-TAP accreditation seal for five of its programs.

Thomas W. Wilson, Ph.D., DrPH, PHII Board Chairperson, notes, "The peer-reviewed H-TAP Standards provide a scientific approach that promotes a more transparent way to view and assess the impact of interventions on stated outcomes. H-TAP allows more legitimate comparisons of claims of effectiveness across programs using different methodologies."

"Nurtur is proud to be the first health management organization to have five of our chronic condition management programs accredited pursuant to the H-TAP Standards," comments Bryan Mullen, Nurtur Chief Information Officer. "Historically the area of evaluation and measurement has been the subject of much debate and contention in the disease management industry. By participating in the extremely rigorous PHII review process, and successfully completing the H-TAP accreditation for our programs, we continue to provide the confidence of transparency in demonstrating program impact to our clients."

Nurtur received full H-TAP Accreditation for disease management programs in Asthma, COPD, Cardiac, Heart Failure, and Diabetes.

Other companies have recently submitted H-TAP accreditation applications. These companies offer a wide range of health care services and products. Among a growing list of applicants, those programs "in process" for H-TAP accreditation include:

  • WINhealth Partners, an HMO based in Che
    '/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
2. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
3. Cancer stem cell subpopulation drives metastasis of human pancreatic cancer
4. Planning for 2020: increasing elderly population poses huge challenges in cancer care
5. Migrating Tick Populations Pose Year-Round Disease Threat for People and Pets
6. Those With Disabilities as Well as Aging Population Throughout Country Now Have Access to Thousands of Specialized Products
7. Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase
8. Population Covered by Dental Benefits Increases
9. The widening mortality gap between people with rheumatoid arthritis and the general population
10. Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference
11. Study projects 60 percent increase in ESRD population by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District of ... C.R. Bard, Inc. in that proceeding’s first bellwether trial. In ... request for a new trial after finding that C.R. Bard ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... was forced to take dramatic action in order to ensure that ... the local DHB began trying to get his wife's anti-nausea drug ... provided with the drug. ,Joanne Piper says that the ... Hawke's Bay hospital refused to provide enough of the drug so ...
... which manufactures contact lens solution. But recently it was found ... After this report the Food and Drug Administration ... extensive microbiological testing conducted which would take up to one ... Bausch & Lomb stopped shipping the solution, called ReNu with ...
... Gosling donated a part of his liver to a 5-year old ... //. He further stated that he had no regrets about donating ... life at risk, adding that he would do it again, if ... of his family friends is said to have been instrumental in ...
... alert has been sounded by health authorities in Tripura, ... in neighbouring Assam //. The health department of Tripura ... prevent a malaria outbreak in Tripura. ,'We ... health department. Doctors and paramedics have fanned out to ...
... is getting all the more evident after this pathbreaking ... cause obesity in children accoding to the study. // ... on this skyrocketing trend of childhood obesity, which is perhaps ... type of food advertisments targeting children. ,Nearly 5,407 students ...
... a neurodegenerative disease. According to research by physicians at ... that having close friends // and staying in contact ... damaging effects of Alzheimer's disease. The results of the ... David A. Bennett, and his colleagues is the first ...
Cached Medicine News:Health News:46-Year-Old Canada Man Donates A Part Of His Liver To A Complete Stranger 2Health News:Rush Study Shows That Interactions with Friends and Family Prevents Damaging Effects of Alzheimer's disease 2
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader ... and partnership with RCA Medical, a subsidiary of Ascendis ... . Each year, hundreds of millions of ... infections as organisms are transmitted from patient to patient ...
(Date:1/23/2015)... 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the ... Lixte,s lead compound, LB‑100, is being conducted, has been expanded ... Kovach , M.D., the founder and President of Lixte, said ... a single site. Accrual of patients, however, was slower than ...
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... by end of 2007-, EDMONTON, April 16, ... it has selected PX-866 as its next ... the,phosphatidylinositol-3-kinase (PI3 kinase)/ PTEN/AKT pathway, an,important survival ... of human cancer, including glioblastoma. Preclinical data,presented ...
... - As previously announced, primary endpoint not ... treatment with ERBITUX,-, NEW YORK, April 16, ... Squibb Company today,announced detailed results from the ... III trial - comparing ERBITUX(R),(Cetuximab) plus irinotecan ...
Cached Medicine Technology:Biomira Selects PX-866 as Clinical Development Candidate and,Presents Promising Preclinical Data at AACR 2Biomira Selects PX-866 as Clinical Development Candidate and,Presents Promising Preclinical Data at AACR 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: